242 related articles for article (PubMed ID: 3017557)
41. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma.
Berezowski K; Stastny JF; Kornstein MJ
Mod Pathol; 1996 Apr; 9(4):426-9. PubMed ID: 8729984
[TBL] [Abstract][Full Text] [Related]
42. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
Suzuki H; Teshima K; Noda K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
[TBL] [Abstract][Full Text] [Related]
43. Tumor markers in ovarian cancer: tumor-associated antigens.
Barlow JJ; Bhattacharya M
Semin Oncol; 1975 Sep; 2(3):203-9. PubMed ID: 827023
[No Abstract] [Full Text] [Related]
44. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
[TBL] [Abstract][Full Text] [Related]
45. [Immunodiagnosis of ovarian cancer].
Zhang J; Cao Z; Sun Z; Sun Z
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):325-8. PubMed ID: 1748422
[TBL] [Abstract][Full Text] [Related]
46. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
Heald J; Buckley CH; Fox H
J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
[TBL] [Abstract][Full Text] [Related]
47. A review of tumor antigens in gynecologic malignancies.
Gall SA
J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
[TBL] [Abstract][Full Text] [Related]
48. Characterization of a common antigen of colorectal and mucinous ovarian tumors, COTA.
Pant KD; Zamora PO; Rhodes BA; Sachatello CR; Hagihara PF; Griffen WO; van Nagell JR; Fulks R; Ram MD
Tumour Biol; 1984; 5(5):243-54. PubMed ID: 6442455
[TBL] [Abstract][Full Text] [Related]
49. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
50. [CEA and related antigens as possible new tumor markers].
Matsuoka Y
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1754-63. PubMed ID: 6688338
[TBL] [Abstract][Full Text] [Related]
51. Is there a correlation between tumor marker panel and tumor size and histopathology in well staged patients with borderline ovarian tumors?
Ayhan A; Guven S; Guven ES; Kucukali T
Acta Obstet Gynecol Scand; 2007; 86(4):484-90. PubMed ID: 17486473
[TBL] [Abstract][Full Text] [Related]
52. Expression of carcinoembryonic antigen and nonspecific cross-reacting 50-kDa antigen in human normal and cancerous colon mucosa: comparative ultrastructural study with monoclonal antibodies.
Baranov V; Yeung MM; Hammarström S
Cancer Res; 1994 Jun; 54(12):3305-14. PubMed ID: 8205554
[TBL] [Abstract][Full Text] [Related]
53. Carcinoembryonic antigen in primary and metastatic ovarian tumors.
Fleuren GJ; Nap M
Gynecol Oncol; 1988 Jul; 30(3):407-15. PubMed ID: 2839395
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
[TBL] [Abstract][Full Text] [Related]
55. Hypoxic status in ovarian serous and mucinous tumors: relationship between histological characteristics and HIF-1alpha/GLUT-1 expression.
Iida T; Yasuda M; Miyazawa M; Fujita M; Osamura RY; Hirasawa T; Muramatsu T; Murakami M; Saito K; Mikami M
Arch Gynecol Obstet; 2008 Jun; 277(6):539-46. PubMed ID: 18026974
[TBL] [Abstract][Full Text] [Related]
56. Characterization of the carcinoembryonic antigen activity associated with cyst fluids of mucinous ovarian cystadenocarcinoma.
Yamashita K; Aitio ML; Dawson JR
Cancer Res; 1979 May; 39(5):1760-5. PubMed ID: 85489
[TBL] [Abstract][Full Text] [Related]
57. Ovarian tumor antigens.
Bhattacharya M; Barlow JJ
Cancer; 1978 Sep; 42(3 Suppl):1616-20. PubMed ID: 81712
[TBL] [Abstract][Full Text] [Related]
58. [The evaluation of CA54/61 in the diagnosis of ovarian cancer--with special reference to the cooperative results of 5 institutes].
Nozawa S; Yajima M; Udagawa Y; Kiguchi K; Iizuka R; Kimura E; Terashima Y; Inaba N; Takamizawa H; Negishi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1823-9. PubMed ID: 2687409
[TBL] [Abstract][Full Text] [Related]
59. Morphological and immunological heterogeneity of human ovarian neoplasms.
Harłozińska A; Rabczyński J; Bar JK; Richter R
Arch Immunol Ther Exp (Warsz); 1991; 39(4):419-29. PubMed ID: 1821619
[TBL] [Abstract][Full Text] [Related]
60. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
